XSpray Pharma AB (XSPRAY) — Working Capital to Net Assets Ratio
XSpray Pharma AB (XSPRAY) has a Working Capital to Net Assets ratio of 9.5% as of June 2026. Working capital of Skr60.49 Million (current assets of Skr215.11 Million minus current liabilities of Skr154.62 Million) is measured against net assets of Skr637.50 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See XSpray Pharma AB (XSPRAY) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
XSpray Pharma AB Working Capital to Net Assets (2015–2025)
This chart shows how XSpray Pharma AB's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 9.5%, reflecting working capital of Skr60.49 Million against net assets of Skr637.50 Million SEK. For the complete balance sheet picture, see XSpray Pharma AB balance sheet assets.
Annual Working Capital to Net Assets for XSpray Pharma AB (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for XSpray Pharma AB from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are XSpray Pharma AB's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 26.7% | Skr161.23 Million | Skr604.65 Million | Skr182.90 Million | Skr21.66 Million | ▲ +12.4 pp |
| 2024 | 14.3% | Skr88.93 Million | Skr623.10 Million | Skr235.07 Million | Skr146.14 Million | ▼ -11.4 pp |
| 2023 | 25.7% | Skr177.91 Million | Skr693.41 Million | Skr217.81 Million | Skr39.90 Million | ▲ +7.1 pp |
| 2022 | 18.6% | Skr103.38 Million | Skr556.02 Million | Skr132.23 Million | Skr28.85 Million | ▼ -24.0 pp |
| 2021 | 42.6% | Skr252.10 Million | Skr591.75 Million | Skr282.06 Million | Skr29.97 Million | ▼ -10.8 pp |
| 2020 | 53.4% | Skr311.20 Million | Skr582.59 Million | Skr331.01 Million | Skr19.82 Million | ▲ +1.6 pp |
| 2019 | 51.8% | Skr193.62 Million | Skr373.71 Million | Skr216.13 Million | Skr22.50 Million | ▼ -19.8 pp |
| 2018 | 71.6% | Skr216.09 Million | Skr301.72 Million | Skr226.86 Million | Skr10.77 Million | ▼ -0.1 pp |
| 2017 | 71.7% | Skr111.59 Million | Skr155.66 Million | Skr117.34 Million | Skr5.75 Million | ▲ +16.0 pp |
| 2016 | 55.7% | Skr25.87 Million | Skr46.47 Million | Skr31.26 Million | Skr5.39 Million | ▼ -30.8 pp |
| 2015 | 86.5% | Skr10.61 Million | Skr12.26 Million | Skr13.29 Million | Skr2.69 Million | — |